Aura Biosciences grants CMO 58,850 RSUs, options
Hopkins’ new RSUs vest starting Sept. 15, 2027 in four yearly installments, while her option begins monthly vesting Oct. 1, 2026 over 48 months.
Rhea-AI Filing Summary
Aura Biosciences, Inc. (AURA) reported that Chief Medical Officer Janet Jill Hopkins received equity compensation awards. She was granted 58,850 RSUs, each representing one share of common stock upon vesting, and a stock option for 116,150 shares of common stock at an exercise price of $7.43 per share. The RSUs vest in four substantially equal annual installments starting September 15, 2027, and the option vests monthly over 48 months starting October 1, 2026, with an expiration date of September 1, 2036. Following these grants, she directly holds 380,190 common shares, excluding unexercised options.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 175,000 shares
Grant/Award
2 txns
Insider
Hopkins Janet Jill
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 116,150 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 58,850 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 116,150 contracts (Direct);
Common Stock — 380,190 shares (Direct)
Footnotes (2)
- F1. The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027.
- F2. The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026.
Key Figures
RSUs granted: 58,850 shares
Stock options granted: 116,150 shares
Option exercise price: $7.43 per share
+4 more
7 metrics
RSUs granted
58,850 shares
Restricted stock units granted to CMO on 2026-09-01
Stock options granted
116,150 shares
Option award to buy common stock on 2026-09-01
Option exercise price
$7.43 per share
Exercise price for 116,150-share stock option
Common shares held after transaction
380,190 shares
Directly owned common stock position after grants
Option expiration date
2036-09-01
Expiration of 116,150-share stock option
RSU first vesting date
2027-09-15
First annual tranche of RSU vesting
Option first vesting date
2026-10-01
First monthly tranche of option vesting
Key Terms
restricted stock units, 2021 Stock Option and Incentive Plan, vesting, stock option
4 terms
restricted stock units financial
"represents a grant of restricted stock units ("RSUs") under the Issuer's 2021"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2021 Stock Option and Incentive Plan financial
"grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan"
vesting financial
"These RSUs shall vest in four substantially equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
stock option financial
"The stock option shall vest as to 1/48th of the total award monthly"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What equity awards did AURA grant to Chief Medical Officer Janet Jill Hopkins?
Janet Jill Hopkins received 58,850 RSUs and a stock option for 116,150 shares of Aura Biosciences common stock at an exercise price of $7.43 per share, reported as compensation awards rather than open-market purchases.
How do the new RSUs for AURA’s CMO vest?
The 58,850 RSUs granted to AURA’s CMO vest in four substantially equal annual installments, subject to continued service, with the first tranche vesting on September 15, 2027.
What are the vesting terms of the new stock option reported for AURA?
The stock option for 116,150 shares vests as to 1/48th of the award monthly, starting on October 1, 2026, contingent on the CMO’s continued service to Aura Biosciences, and expires on September 1, 2036.
Were the AURA Form 4 transactions open-market buys or compensation awards?
Both transactions were reported under code A as a grant, award, or other acquisition. Footnotes indicate they are grants of RSUs and stock options under the 2021 Stock Option and Incentive Plan, not open-market purchases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
